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Abstract— Brain Metastases (BM) complicate 20-40% of 
cancer cases. BM lesions can present as punctate (1 mm) 
foci, requiring high-precision Magnetic Resonance 
Imaging (MRI) in order to prevent inadequate or delayed 
BM treatment. However, BM lesion detection remains 
challenging partly due to their structural similarities to 
normal structures (e.g., vasculature). We propose a BM-
detection framework using a single-sequence gadolinium-
enhanced T1-weighted 3D MRI dataset. The framework 
focuses on detection of smaller (< 15 mm) BM lesions and 
consists of: (1) candidate-selection stage, using Laplacian 
of Gaussian approach for highlighting parts of a MRI 
volume holding higher BM occurrence probabilities, and 
(2) detection stage that iteratively processes cropped 
region-of-interest volumes centered by candidates using a 
custom-built 3D convolutional neural network (“CropNet”). 
Data is augmented extensively during training via a 
pipeline consisting of random gamma correction and 
elastic deformation stages; the framework thereby 
maintains its invariance for a plausible range of BM shape 
and intensity representations. This approach is tested 
using five-fold cross-validation on 217 datasets from 158 
patients, with training and testing groups randomized per 
patient to eliminate learning bias. The BM database 
included lesions with a mean diameter of ~5.4 mm and a 
mean volume of ~160 mm3. For 90% BM-detection 
sensitivity, the framework produced on average 9.12 false-
positive BM detections per patient (standard deviation of 
3.49); for 85% sensitivity, the average number of false-
positives declined to 5.85. Comparative analysis showed 
that the framework produces comparable BM-detection 
accuracy with the state-of-art approaches validated for 
significantly larger lesions. 
 
Index Terms— magnetic resonance imaging, brain 
metastases, convolutional neural networks, deep learning, 
scale-space representations, computer-aided detection, 
medical image analysis. 
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I. INTRODUCTION 
RAIN metastases (BM) are disseminated cancer 
formations commonly originating from breast cancer, 
lung cancer, or malignant melanoma [1]. Detection of BM is a 
tedious and time-consuming manual process for radiologists, 
with no allowance for reduced accuracy; missed detections 
potentially compromise the success of treatment planning for 
the patient. Accordingly, computer-aided detection approaches 
have been proposed to assist radiologists by automatically 
segmenting and/or detecting BM in contrast-enhanced 
Magnetic Resonance Imaging (MRI) sequences, which is the 
key modality for the detection, characterization, and 
monitoring of BM. Methods utilizing traditional image 
processing and machine learning techniques, such as template 
matching [2][3][4], 3D cross-correlation metrics [5], fuzzy 
logic [6], level sets [7], and selective enhancement filtering [8] 
are reported to produce promising results. In recent years, 
Convolutional Neural Network (CNN) based approaches have 
started to be used extensively in a variety of medical imaging 
problems [9], and this holds great promise for BM evaluation.  
To our knowledge, the application of a Deep Neural 
Network (DNN) to segmentation of BM in MRI datasets was 
first introduced by Losch et al. [10]. Besides analyzing the 
impact of different network structures on the segmentation 
accuracy, their study also showed that a DNN can produce 
comparable or even better results with respect to previously 
reported state-of-art approaches. However, a limitation of their 
approach was a significant reduction in accuracy for the 
segmentation of tumors with sizes below 40 mm3. 
Charron et al. [11] used DeepMedic neural network [12] for 
segmenting and detecting BM in multi-sequence MRI datasets 
as input, including post-contrast T1-weighted 3D, T2-
weighted 2D fluid-attenuated inversion recovery, and T1-
weighted 2D sequences. The study involved investigation of 
the impacts of epoch, segment, and/or batch sizes on overall 
accuracy, thus providing a well-documented hyper-parameter 
optimization process. The BM considered in their study had a 
mean volume of 2400 mm3, and the system detected 93% of 
lesions whereas producing 7.8 average false-positive 
detections per patient. 
Liu et al. proposed a modified DeepMedic structure, “En-
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DeepMedic” [13], with the expectation of improved BM 
segmentation accuracy and higher computational efficiency. 
The approach was validated with both the BRATS database 
[14] and their post-contrast T1-weighted MRI collection of 
brain metastases with a mean tumor volume of 672 mm3. The 
system yielded an average Dice similarity coefficient of 0.67, 
where the detection false-positive rate in connection to the 
sensitivity percentage is not reported. 
More recently, Grøvik et al. [15] demonstrated the usage of 
2.5D fully CNN, based on GoogLeNet architecture [16], for 
detection and segmentation of BM. Their solution utilized 
multiple sequences of MRI for each patient: T1-weighted 3D 
fast spin-echo (CUBE), post-contrast T1-weighted 3D axial 
IR-prepped FSPGR, and 3D CUBE fluid-attenuated inversion 
recovery. Their database included 156 patients, with testing 
performed on 51 patients. For the detection of BM, at 83% 
sensitivity, average number of false-positives per patient is 
reported as 8.3. 
The motivation for our study is to provide a BM-detection 
framework for 3D T1-weighted contrast-enhanced MRI 
datasets that focuses on small lesions (≤15 mm) with an 
average volume of only ~160 mm3. Such tiny lesions are 
difficult for even experienced neuroradiologists to detect, and 
missed lesions can lead to inadequate or delayed treatment. To 
our knowledge, no prior work focused on BM with volumes 
smaller than 500 mm3. Detection of small lesions is 
particularly important given the clinical challenge they 
represent and due to recent paradigm shift in how these lesions 
are treated with radiation. In the past, patients with multiple 
intracranial metastases were treated with whole brain 
radiation, making detection of individual lesions not as 
crucial. However, due to long-term cognitive decline 
associated with whole brain radiation, recent radiation 
treatment regimens target individual lesions, consequently 
making detection of even a tiny lesion crucial for the 
appropriate treatment [17]. 
This report first provides the following components of the 
detection framework: (1) Candidate BM selection procedure, 
(2) training strategy, (3) data augmentation pipeline, and (4) 
CNN architecture. Next, a description of the medical data used 
in the study, BM data statistics, and its acquisition are 
presented. The evaluation criteria are then defined, and the 
motivation behind the use of the average number of false 
lesion-detections per patient in connection to the detection 
sensitivity is justified. Next, the results are provided based on 
a five-fold Cross-Validation (CV) executed on 217 datasets. 
Finally, it is concluded with: (1) Comparisons with other state-
of-art techniques in the field, (2) summary of the novelties of 
the introduced study, (3) system limitations, and (4) future 
work indicators. 
II. METHODS AND MATERIALS 
The BM-detection framework consists of two main 
components: (1) Candidate-selection step, and (2) a 
classification stage. First, the input MRI volume is processed 
using an information-theory based approach for detection of 
image points with high probability of representing BM. Next, 
volumetric regions centered by these candidate locations are 
iteratively fed into a custom-built CNN, CropNet, with 
extensive data augmentation, including rigid and non-rigid 
geometric transformations and intensity-based 
transformations. CropNet is a classification network, trained 
and validated to determine the probability of a given 
volumetric image to contain a BM.  Algorithmic details of 
these stages are further described in the following subsections. 
A. Metastasis Candidate Selection 
The visual appearance of metastatic masses can be 
generalized to blob-shaped formations either with relatively 
brighter or darker interiors (i.e., due to central necrosis). Blob-
detection has been previously addressed using various 
generalized scale-space methods [18], including the Laplacian 
of Gaussian (LoG) approach [19]. In the proposed detection 
framework, LoG is utilized for detecting BM candidates for a  
given MRI volume as it: (1) Avoids image noise via its 
inherited Gaussian filtering properties, (2) holds few 
parameters to optimize, and (3) robustly detects BM 
candidates, with sensitivity reported in the Results section. 
Yu et al. deployed LoG in the detection stage of their BM 
segmentation approach for MRI images [20], solidifying the 
applicability of LoG in the domain of our study. We further 
enhance the approach with sensitivity constraints and use it in 
candidate selection. 
Given volumetric image data , scale-space representation 
can be defined as, 
 
  (1) 
 
where  is the scale, and  gives the scale-space representation 
at . Accordingly, the scale-normalized Laplacian operator is: 
  
  (2) 
 
Local optima of the above equation, which are 
maxima/minima of   with respect to both space and 
scale, represents the blob center positions [19].   
The BM candidate-selection process aims to determine a set 
of image points that are closely located to the metastatic mass 
centers. Keeping the candidate list as short as possible is one 
of the main objectives for the process.  However, the 
sensitivity of the framework needs to be maintained, which 
implies a comprehensive list of candidates. As these objectives 
are working against each other, the optimization process can 
be described as a minimax problem: 
 
  (3) 
  (4) 
 
where   defines the sensitivity of the system based on (1)  
representing the list of actual BM centers, and (2)  
denoting candidate points selected for input volume  with 
LoG parameters of . As the sensitivity of the system is the 
major criterion in this study, we propose a solution where the 
sensitivity portion of the equation is constrained as  
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  (5) 
 
with   giving the minimal allowed sensitivity (e.g., 95 
percent), and  is found via grid search [21] constrained with 
Equation-4. 
B. Network Training 
The DNN described in the following subsection aims to 
classify each BM candidate as positive (implies that the 
candidate point holds high probability for being a center of 
metastatic mass) or negative. The candidate-selection 
procedure using the LoG approach with sensitivity constraint, 
as described previously, produces candidates in magnitudes of 
thousands (please refer to Results section for actual numbers). 
Fortunately, only a few of the computed candidates are actual 
BM. Thus, the network training should factor in highly 
unbalanced class representations. The proposed detection 
framework addresses this using (1) random paired data 
selection strategy, and (2) on the fly data augmentation stage 
aiming to represent the covariance of tumor representations 
using a stochastic methodology. 
During the training of the DNN, at each batch iteration, a 
pair of positive and negative samples are selected from each 
dataset randomly, producing a batch of 2  samples where N is 
the number of training cases. Next, the given batch is 
augmented on the fly [22], and the DNN is trained with the 
augmented batch (see Fig.1, row A). The term “epoch” is not 
used in this definition; as in the proposed framework, the 
samples are processed in a random pair basis, whereas epoch 
commonly refers to complete pass through all training data. 
The augmentation process is the key for the introduced 
detection framework’s learning invariance. The BM sample 
count is a small fraction of the total amount of samples—the 
learning process heavily depends on properly generalizing 
intensity and shape variations of BM. The importance of data 
augmentation for general computer vision and similar medical 
imaging scenarios are further described in [23] and [24], 
respectively. The detection framework deploys an 
augmentation pipeline consisting of random (1) elastic 
deformation, (2) gamma correction, (3) image flipping, and (4) 
rotation stages (see Fig.1, row B). In the following 
subsections, technical details for random elastic deformation 
and random gamma correction augmentations are provided. 
Next, the CNN, which processes the augmented positive and 
negative sample volumes, is further described.  
 
1) Random Elastic Deformations 
Plausible non-rigid augmentations of the BM regions are 
produced by generalizing the random elastic deformation field 
generation algorithm proposed by Simard et al [25] from 2D 
to 3D. For a given volumetric image data , random 
displacements fields , , and  are defined, where each 
of these has similar dimensions as , and their voxels hold 
random values picked from a uniform distribution defined in 
the range of . Next, these random fields are smoothed 
with a zero-centered Gaussian kernel with a standard deviation 
of  (defined in mm). Finally, the deformation field is scaled 
with an elasticity coefficient . Choice of  causes elastic 
deformation to be (1) pure random with , and (2) 
almost affine with , whereas  determines the 
magnitude of the introduced local deformations (Fig. 2). 
The usage of elastic deformations in the augmentation stage 
is crucial for the proposed framework, as it facilitates the 
generation of a conceivable BM shape domain. However, the 
algorithm needs to be used with well-tested parameters to 
ensure the viability of the augmented BM samples. In their 
paper, Simard et al. suggest the usage of   and , 
 
 
Fig. 1.  Row A: Compilation of the positive & negative pair batch is represented. Positive and negative samples (shown with yellow and green 
rectangles respectively), are selected from BM candidates shown with red spheres in each dataset. Row B: Each positive sample goes through 
augmentation process: (B-1) mid-axial slice of an original cropped sample, (B-2) random elastic deformation is applied, (B-3) random gamma 
correction is applied, (B-4) sample volume is randomly flipped, and (B-5) sample volume is randomly rotated. The middle part of the randomly 
cropped volume, shown with a dashed red square in B-5, is used for the training. Face regions are covered to protect patient privacy. 
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as it yielded the best results in their analyses. Our framework 
adopted those optimal parameters after visual inspections by a 
medical expert. 
 
2) Random Gamma Corrections 
In MRI, tissues do not have consistent intensity ranges, 
such as in computed tomography. Usage of bias field 
correction might improve the predictability of tissue 
intensities. However, its success is limited due to machine-
dependent parameters [26]. Medical image processing 
algorithms, both information-theory and DNN based, benefit 
from understanding the probabilistic distributions of tissue 
intensity values. One way to achieve this goal is the 
normalization of image intensities in MRI to represent the 
target tissues with predefined intensity ranges [27]. Using 
even order derivatives of the histogram [28], Gaussian 
intensity normalization of selected tissues [29], and utilizing 
the median of intensity histogram [30] are some of the 
approaches introduced for that purpose. However, these 
methods are shown to be prone to errors as they aim to define 
approximations to non-linear intensity matching problems. 
The region-based approach [31], is shown to be effective, as it 
divides the spatial domain into smaller regions to address this 
limitation via piecewise linear approximations.  
In the proposed framework, a novel form of the region-
based strategy is introduced; random gamma corrections are 
applied to cropped volumetric regions during the 
augmentation stage [32]. Accordingly, the framework (1) does 
not make any assumptions about the histogram shape or 
intensity characteristics of given MRI datasets, and (2) avoids 
losing or corrupting potentially valuable intensity features, 
which is a common disadvantage of image intensity 
normalization-based methods. 
Gamma correction of given volumetric data is given by, 
  
  (6) 
 
where  is the intensity scaled volumetric image data in  
range,  is the gamma value, and  is the gamma-corrected 
volumetric image data, which is also intensity scaled (see Fig. 
3).  
 In the detection framework, the gamma correction 
augmentations are utilized by randomly picking  values from 
a uniform distribution defined in  range, determined 
empirically by investigating the visual appearance of gamma-
corrected volumetric regions. 
 
3) Network Architecture 
The CNN introduced in this study (i.e., CropNet) has an 
input layer with an isotropic-sampled volumetric region of 
interest (ROI), where each voxel represents 1 mm3. Please 
note that the input volume’s edge length is used in model 
naming, such as CropNet- mm, where  is the volume’s 
edge length in mm. Besides, the model follows a typical 
contracting path structure: Each resolution level is formed 
using stacked blocks each consisting of convolution, rectified 
linear activation unit (ReLU) and dropout layers. Block count 
per resolution level is another configurable parameter for the 
introduced network, hence, included in the naming convention 
as CropNet-b , where  denotes the number of blocks per 
level. The network’s downsampling is performed via 
 max-pooling, followed with channel doubling. The 
output is a one-dimensional scalar produced via the sigmoid 
activation layer, which holds value in the range of  
representing the likelihood of a given ROI to contain a 
metastatic mass. The network’s convolution layers are 
initialized using Glorot uniform initializer as described in [33].  
In Fig.4, the formation of network architecture is illustrated 
for two blocks and 32 mm edge length (CropNet-b2-32mm), 
thus the reader can associate naming convention with the 
CNN. As described in the Results section, the study employs 
 
Fig. 2. The original cropped volume of a metastatic tumor mass (A), 
random displacement fields for x, y and z axes (B), and the 
corresponding deformed volume (C) are each shown from mid-axial, 
sagittal, and coronal views. 
  
 
 
Fig. 3.  The effects of gamma correction on region centering ~2.2mm 
diameter metastasis (mid axial slice of a cropped 3D volume). Please 
note that γ=1.0 represents the original image. 
  
 
 
Fig. 4.  CropNet-b2-32mm: Input of this CNN is 32mm x 32mm x 32mm 
isotropic region-of-interest, and each resolution level consists of two 
identical blocks, where the output is a scalar in range of [-1, 1]. 
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16 mm version of CropNet, as (1) the target objects have 
diameters smaller than 15 mm, and (2) CropNet-b2-16mm 
produced comparable performance and allowed faster training 
with respect to its higher edge length versions (i.e. 32 and 64 
mm).  
III. DATABASE 
A. Data Collection 
This retrospective study was conducted under Institutional 
Review Board approval with waiver of informed consent 
(institutional IRB ID: 2016H0084). A total of 217 post- 
gadolinium T1-weighted 3D MRI exams were collected from 
158 patients: 113 patients with a single dataset, 33 patients 
with 2 datasets (i.e. one follow-up examination), 10 patients 
with 3 datasets, and 2 patients with 4 datasets. Two of the 
major study selection parameters were that (1) none of the 
datasets involved lesions with diameter of 15 mm or larger, 
and (2) motion degraded studies were included. 
Ground-truth BM segmentation masks were prepared by a 
radiologist, using a custom-built tool for the project [34]. The 
tool was developed using MeVisLab 2.8 (medical image 
processing and visualization framework developed by MeVis 
Medical Solutions AG), and it allows users to load volumetric 
MRI datasets, manually delineate the borders of BM, and edit 
the existing segmentation masks if needed (see Fig.5).  
B. Brain Metastases 
The database included 932 BMs where, (1) mean number of 
BMs per patient is 4.29 (σ = 5.52), median number per patient 
is 2, (2) mean BM diameter is 5.45 mm (σ = 2.67 mm), 
median BM diameter is 4.57 mm, and (3) mean BM volume is 
159.58 mm3 (σ = 275.53 mm3), median BM volume is 50.40 
mm3. Fig.6 (A, B and C), provides the histograms for each of 
these distributions. 
For better understanding of the localization of BMs 
included in our database, all BMs are registered on a reference 
MRI image, and the probability density function is generated 
for multiple projections in Fig.6 (D). The volumetric 
registration for this illustration is performed by maximizing 
the mutual information between the reference MRI volume, 
and the rest of the volumes in the database iteratively, 
maximizing: 
 
  (7) 
 
 
Fig. 5.  The screenshot of the custom tool allowing medical experts to 
create, edit, save/load segmentation masks of BMs in MRI images. 
The tool provides 2D axial view, 3D view, and various manual editing 
tools.     
 
 
Fig. 6. The histograms for (A) number of BM per patient, (B) diameters of BM, and (C) volumes of lesions in BM database are shown. Below, the 
BM probability density function’s projections on left sagittal (D-1), axial (D-2), and coronal (D-3) planes are provided. Face region is covered to 
protect patient privacy. 
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Fig. 9.  The framework output; white circles centered by the BM detections are rendered (yellow arrows are added to the figure for the readers’ 
convenience). 
  
   
where  is the floating volume (i.e. any volume picked from 
the database),  is the reference volume,  is the 
Shannon entropy of the reference volume, and  is 
the conditional entropy. Rigid registration, optimizing 
translation and rotation parameters, is utilized in our 
visualization. The interested reader may refer to [35] for 
further details on mutual information’s usage in medical 
image registration.  
 
C. Evaluation Metric 
The clinical applicability of a BM-detection algorithm was 
assessed by measuring (1) the sensitivity and (2) the average 
number of false lesion-detections for a given sensitivity.  
As a screening tool, sensitivity of the system is expected to 
be high: In a typical deployment scenario of a detection 
algorithm, the appropriate operating point, maximizing the 
sensitivity whereas minimizing the average false lesion-
detections per patient, needs to be adjusted by a medical 
expert. Therefore, we plot our performance metrics (i.e. 
sensitivity vs average number of false-positive detections per 
patient - AFP) at various output threshold settings (~0 – low 
likelihood and ~1 – high likelihood of metastasis). 
Accordingly, state-of-art approaches[10][11][15] follow a 
similar reporting methodology. 
IV. RESULTS 
The detection framework is validated using 5-fold CV.  
Folds are generated based on patient, which ensures each 
patient is located either in a training or testing group for each 
fold (e.g. datasets from Patient-A are all located either in 
training or testing group for fold-n) for eliminating the 
learning bias. Accordingly, the bins included datasets from 31, 
31, 32, 32 and 32 patients, respectively. For each CV fold, 
four bins are used for the training and validation, and a single 
bin is used for the testing. 
For the candidate selection stage of the framework, 
Laplacian of Gaussian parameters are optimized from the 
training bins with the constraint of setting minimal sensitivity 
to 95% (see Equation-5). These parameters include (1) 
minimal and maximal standard deviations for the Gaussian 
kernel, and (2) the absolute lower bound for scale-space 
maxima, also referred to as LoG threshold in the literature 
[19]. The candidate-selection procedure achieved (1) a mean 
sensitivity of 95.8, where the sensitivity for training and 
testing groups of each fold are represented in Fig.7, and (2) 
produced 72623 candidates on average (σ = 12518) for each 
3D dataset. Processing time for each dataset is ~30.6 seconds 
(using a 3.5 GHz Intel Core i7-5930K CPU. 
 
Fig. 7.  Candidate selection procedure’s sensitivity percentages for 
each fold’s training (blue) and testing (silver) groups are represented. 
Sensitivity standard deviations are also shown with bold lines on each 
block. 
 
 
Fig. 8. Average number of false-positives per patient (i.e., wrongly 
detected BM lesions for each patient) in relation to the sensitivity is 
illustrated for each CV fold. The mean curve (shown with black) 
represents the average of the CV folds. 
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The framework contained CropNet-b2-16mm for processing 
the BM candidates and providing the final detection results. 
The network processed cubic ROIs with 16mm edges and each 
resolution level included two blocks with layers as described 
in Section.2. For each fold, CropNet is trained for 20000 batch 
iterations. The optimal version of the network is determined 
using the minima of moving validation loss average, computed 
over 30 batch iterations. On average, the training process took 
11312 (σ = 183) batch iterations to converge.  The network’s 
training time for each fold was ~3.5 hours using an NVIDIA 
1080ti graphics card with 11 GB RAM. 
The average number of false-positives (i.e. false lesion-
detections) per patient (AFP) were computed in connection to 
the sensitivity of the framework for each CV fold, where the 
sensitivity of the framework was adjusted via setting a 
threshold at CropNet’s response. AFP was computed as 9.12 
per patient with a standard deviation of 3.49 at 90 percent 
sensitivity. At lower sensitivity percentages, AFP was 
computed as 8.48 at 89%, 7.92 at 88%, 7.29 at 87%, 6.64 at 
86%, and 5.85 at 85% (see Fig.8). Fig. 9 illustrates sample 
output screens for the deployed BM detection framework.  
V. DISCUSSION AND CONCLUSION 
Table.1 provides an overview of the databases, acquisition 
types, neural network architectures, validation strategies and 
detection accuracies of some of the prominent CNN based 
BM-detection/segmentation approaches for 3D MRI, 
published over the recent years. From these, [11] and [15] 
requires multiple MRI sequences during the BM-
segmentation/detection process, whereas [13] benefited from 
multiple sequences for the training and validation. Our 
framework trained and validated for a single type of MRI 
sequence, T1c, and requires only this type of study during its 
decision-making process. 
The dimensional properties of the BM included in a 
detection study are critical for determining the clinical 
applicability of a proposed solution. This is due to the fact that 
smaller lesions are harder to identify even by highly trained 
neuroradiologists. Consequently, they may greatly benefit 
from a system trained and validated specifically for that type 
of data. As illustrated in Table.1, our study employed a BM 
database that included relatively smaller BM lesions compared 
with the referenced studies; the smallest BM average volume 
in comparable studies is 672 mm3 [13], whereas the BM 
average volume in this study is only 159.58 mm3. 
BM-detection and segmentation databases used in our study 
and in other comparable studies (as shown in Table.1) are 
limited with respect to number of cases; they all consist of 
some hundreds of patients. Estimating the accuracies of such 
machine learning approaches, trained with a limited amount of 
datasets, can gain significantly from the usage of CV, as the 
method minimizes the error of algorithm’s predictive 
performance evaluation [36]. Therefore, we found it valuable 
to emphasize the validation schemes of comparable studies in 
Table.1. 
The study introduced multiple technical novelties: (1) 
Sensitivity constrained LoG BM-candidate selection, (2) 
random 3D Simard elastic deformation augmentations (Simard 
deformation field used for medical-image augmentation for 
the first time to our knowledge), (3) volumetric random 
gamma correction augmentations for MRI, and (4) a 
parametric CNN for processing cubic volumes of interests. 
More importantly, all of these components are put into a sound 
framework that can be utilized for various detection 
applications in medical imaging. 
The limitations of the proposed solution are (1) its scope is 
currently limited to the detection; medical interventions 
requiring exact borders of detected tissues (such as stereotactic 
radiotherapy) may not benefit from the method, and (2) 
lesions with sizes larger than 15 mm would not be detected 
TABLE I 
OVERVIEW OF BM DETECTION/SEGMENTATION STUDIES THAT USE CONVOLUTIONAL NEURAL NETWORKS 
Study Patient # Acquisition 
BM diameter 
(mm) 
BM volume 
(mm) DNN Type Validation Type 
Sensitivity 
(%) AFP 
Losch et al. [10] 490 T1c MRI  NA NA 
 
Multi-scale ConvNet Fixed train/test e 82.8 7.7 
Liu et al. [13] 490 Multi seq.a NA Mean: 672 
 
En-DeepMedic 5-fold CV NA NA 
Charron et al. [11] 182 Multi seq.b Mean: 8.1 
Median: 7 
Mean: 2400 
Median: 500 
 
DeepMedic Fixed train/test f 93 7.8 
Grøvik et al. [15] 156 Multi seq.c NA NA 
 
GoogLeNet d Fixed train/test g 83 8.3 
This study 158 h T1c MRI Mean: 5.4 
Median: 4.6 
Mean: 159.6 
Median: 50.4 
CropNet 5-fold CV 90 9.12 
         
a 235 T1c MRI datasets, and 265 datasets from BRATS DB; including both T1c and T2-weighted Fluid-Attenuated Inversion Recovery (FLAIR) 
sequences. 
b T1-weighted 3D MRI with Gd injection, T2-weighted 2D fluid attenuated inversion recovery MRI and T1-weighted 2D MRI sequences. 
c Pre- and post-gadolinium T1-weighted 3D fast spin echo (CUBE), post-gadolinium T1-weighted 3D axial IR-prepped FSPGR (BRAVO), and 
3D CUBE fluid attenuated inversion recovery (FLAIR) sequences. 
d 2.5 dimensional fully connected convolutional net based on GoogLeNet. 
e 440 training and 50 test cases. 
f 164 training and 18 test cases. 
g 100 training, 5 development and 51 test cases. 
h 217 datasets are collected from 158 patients, CV folds are created patient-wise to ensure a patient can only exist either in training or testing 
group. 
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with a system trained with the parameters given in this paper. 
However, BM-candidate selection and CropNet parameters 
can be reset for the dimensional properties of the target 
tumors. 
The performances of machine-learning algorithms, 
including the CNNs, heavily depend on their hyperparameter 
settings [37]. Accordingly, some of the BM-segmentation 
studies, such as [10] and [11], provided a set of analyses on 
parameter tuning. The introduced framework’s performance 
also relies on proper setup of multiple parameters, including 
(1) edge length and the block count of CropNet, (2) random 
gamma correction range, and (3) elastic deformation 
parameters, which were found empirically and individually. 
Therefore, multivariate optimization of these in a future study 
might further improve the accuracy of the framework. 
The introduced framework can be extended for 
segmentation of the metastatic mass lesions. The network’s 
contracting layers can be appended with a symmetric set of 
expanding layers as in [24] or [22], and its loss function can be 
changed to Dice similarity coefficient, or another image 
segmentation metric [38], to perform segmentation. 
Alternatively, previously defined BM-segmentation 
algorithms can be modified to use the proposed detection 
framework in their preprocessing stages. 
The proposed data augmentation pipeline uses random 
gamma transformations and elastic deformations to capture the 
BM intensity and shape variabilities. The strategy mimics the 
kernel density estimation with Parzen windows [39], as the 
probability densities of the BM with respect to intensity and 
shape are generated from a small set of actual BM (932 BM) 
and their ranged uniform variations to deploy a uniform kernel 
density. For density estimation problems, it is also common to 
use Gaussian kernel densities [39], which would translate to 
(1) using gamma corrections randomly picked from a normal 
distribution centered at 1 (i.e.,  gives the original image), 
and (2) elastic deformations randomly picked from a bivariate 
distribution centered at  (i.e.  and  implies 
null Simard deformation field). The impact of kernel density 
function to the final accuracy is a topic for a future study. 
This study introduced a novel BM detection framework that 
focused on small lesions. It is validated for its high sensitivity, 
and it produced relatively few false BM detections per patient. 
The results suggest that its detection performance is 
comparable with state-of-art approaches that are validated 
against significantly larger lesions. In addition to technical 
novelties introduced, the study focuses on an increasingly 
important field-of-research that is the detection of small BM in 
order to minimize challenges they pose to both radiologists 
and radiation oncologists in the identification and treatment of 
these lesions to ultimately improve patient care. 
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